Zentynel
Venture capital · Vitacura, Chile · Latin America
Zentynel is a venture capital fund specialized in biotechnology in Latin America, founded by Fundación Ciencia & Vida and Venturance Alternative Assets. It combines capital, scientific knowledge and operating experience to help founders turn science into scalable businesses.
Invests inHealthcare & Biotech
In its own wordsbiotechnologyhuman healthanimal healthdigital healthagtechfoodtech
Your fit with Zentynel
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsZentynel lists 16 checked portfolio companies on its own site and is named in 5 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (82%), AI & Machine Learning (12%) and Food & Agriculture (6%). 40% of its companies are based in United States. It invests most often alongside AIR Capital, Cites and Grid Exponential.
Counts come from funding rounds that name Zentynel, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Zentynel's whole history. Rounds on record name 4 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 67% |
| Series A | 33% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 4 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 80th | 67% of entries at pre-seed or seed |
| Evidence | 95th | 25% of companies confirmed by a round |
| Sector focus | 94th | 82% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| AIR Capital | 2 |
| Cites | 2 |
| Grid Exponential | 2 |
| IndieBio | 2 |
| SOSV | 2 |
| Aisling Capital | 1 |
| Alexia Ventures | 1 |
| Alumni Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers16100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 82% | 15% |
| AI & Machine Learning | 12% | 18% |
| Food & Agriculture | 6% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Zentynel head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Zentynel| Date | Company | Stage |
|---|---|---|
| 4 Oct 2026 | Seed Led | |
| 1 Apr 2026 | Seed Led | |
| 26 Feb 2026 | Seed Led | |
| 20 Jan 2026 | Round | |
| 27 Aug 2025 | Series A |
Round details for Zentynel
Amounts, full round histories and every co-investor in Zentynel's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Antarka develops skincare products using a breakthrough enzyme that repairs UV-induced DNA damage at the molecular level | Healthcare & Biotech | Apr 2026Seed | Page + round | |
| Asclepii develops and sells wound care products, including a nanosilver hydrogel wound dressing | Healthcare & Biotech | Portfolio page | ||
| The company develops a medical device that uses electromagnetic frequency to treat cancer cells | Healthcare & Biotech | Portfolio page | ||
| Axenya provides a corporate health platform with solutions for companies and employees, including audit of medical accounts, dashboards, and predictive health analytics. | Healthcare & Biotech | Aug 2025Series A | Page + round | |
| Biomakers provides genomic testing and data solutions for cancer care and research. | Healthcare & Biotech | Jan 2026Round | Page + round | |
| Fecundis is a biotechnology company developing sperm-centered technologies for assisted reproduction. | Healthcare & Biotech | Portfolio page | ||
| Harmony Biosciences develops medicines for patients with unmet medical needs | Healthcare & Biotech | Portfolio page | ||
| HexemBio combines AI with biology to discover medicines and build regenerative therapies | Healthcare & Biotech | Portfolio page | ||
| The company provides home healthcare services, including hospital care, medical monitoring, and nursing care, among others. | Healthcare & Biotech | Portfolio page | ||
| microTERRA develops functional ingredients that transform the taste and texture of food into deeper, more complex, and memorable sensory experiences. | Food & Agriculture | Portfolio page | ||
| The company is developing therapies for nervous system protection and repair by targeting age-associated conditions of the central and peripheral nervous systems | Healthcare & Biotech | Portfolio page | ||
| MultiplAI Health is developing RNA-based, AI-driven screening technology in the form of a simple blood test to transform how cardiovascular diseases are diagnosed. | Healthcare & Biotech | Portfolio page | ||
| Neocrop Technologies develops new crop varieties using genetic editing and biotechnology services | AI & Machine LearningAI & Machine Learning | Feb 2026Seed · 2 rounds | Page + round | |
| Samay develops an AI wearable for early lung disease diagnosis and monitoring. | Healthcare & Biotech | Portfolio page | ||
| ViewMind measures brain health by capturing eye movements and pupil responses during validated cognitive tasks. | Healthcare & Biotech | Portfolio page | ||
| Xeptiva develops active immunization against validated targets of chronic pain and inflammation in companion animals | Healthcare & Biotech | Portfolio page |
About this data
site last read 7 Nov 2026- Site
- zentynel.com
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 27 Aug 2025
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Zentynel's profile as data
Pull Zentynel's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/zentynel.com
# also
GET /v1/firms/zentynel.com/portfolio
GET /v1/firms/zentynel.com/coinvestors
GET /v1/firms/zentynel.com/news